These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 39030333)

  • 21. Sulfated fucoidan FP08S2 inhibits lung cancer cell growth in vivo by disrupting angiogenesis via targeting VEGFR2/VEGF and blocking VEGFR2/Erk/VEGF signaling.
    Chen H; Cong Q; Du Z; Liao W; Zhang L; Yao Y; Ding K
    Cancer Lett; 2016 Nov; 382(1):44-52. PubMed ID: 27569654
    [TBL] [Abstract][Full Text] [Related]  

  • 22. SLCO4A1-AS1 promotes cell growth and induces resistance in lung adenocarcinoma by modulating miR-4701-5p/NFE2L1 axis to activate WNT pathway.
    Wei Y; Wei L; Li J; Ma Z; Zhang Q; Han Z; Li S
    Cancer Med; 2020 Oct; 9(19):7205-7217. PubMed ID: 32762035
    [TBL] [Abstract][Full Text] [Related]  

  • 23. miR-21-5p promotes lung adenocarcinoma cell proliferation, migration and invasion via targeting WWC2.
    Wang G; Zhou Y; Chen W; Yang Y; Ye J; Ou H; Wu H
    Cancer Biomark; 2020; 28(4):549-559. PubMed ID: 32623387
    [TBL] [Abstract][Full Text] [Related]  

  • 24. miR-212-5p exerts tumor promoter function by regulating the Id3/PI3K/Akt axis in lung adenocarcinoma cells.
    Chen FF; Sun N; Wang Y; Xi HY; Yang Y; Yu BZ; Li XJ
    J Cell Physiol; 2020 Oct; 235(10):7273-7282. PubMed ID: 32039486
    [TBL] [Abstract][Full Text] [Related]  

  • 25. TMEM9 promotes lung adenocarcinoma progression via activating the MEK/ERK/STAT3 pathway to induce VEGF expression.
    Wang Z; Zhao P; Tian K; Qiao Z; Dong H; Li J; Guan Z; Su H; Song Y; Ma X
    Cell Death Dis; 2024 Apr; 15(4):295. PubMed ID: 38664392
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Knockdown of miR-1293 attenuates lung adenocarcinoma angiogenesis via Spry4 upregulation-mediated ERK1/2 signaling inhibition.
    Lou Y; Xu B; Huang K; Li X; Jin H; Ding L; Ning S; Chen X
    Biochem Pharmacol; 2024 Aug; 226():116414. PubMed ID: 38972427
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MiR-191-5p inhibits lung adenocarcinoma by repressing SATB1 to inhibit Wnt pathway.
    Zhou LY; Zhang FW; Tong J; Liu F
    Mol Genet Genomic Med; 2020 Jan; 8(1):e1043. PubMed ID: 31724324
    [TBL] [Abstract][Full Text] [Related]  

  • 28. TM6SF1 suppresses the progression of lung adenocarcinoma and M2 macrophage polarization by inactivating the PI3K/AKT/mtor pathway.
    Huang S; Zhao H; Lou X; Chen D; Shi C; Ren Z
    Biochem Biophys Res Commun; 2024 Jul; 718():149983. PubMed ID: 38718735
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The novel circular RNA circ-CAMK2A enhances lung adenocarcinoma metastasis by regulating the miR-615-5p/fibronectin 1 pathway.
    Du J; Zhang G; Qiu H; Yu H; Yuan W
    Cell Mol Biol Lett; 2019; 24():72. PubMed ID: 31889960
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CircRNA EPB41L2 inhibits tumorigenicity of lung adenocarcinoma through regulating CDH4 by miR-211-5p.
    Zhang SJ; Ma J; Wu JC; Hao ZZ; Zhang YN; Zhang YJ
    Eur Rev Med Pharmacol Sci; 2020 Apr; 24(7):3749-3760. PubMed ID: 32329852
    [TBL] [Abstract][Full Text] [Related]  

  • 31. microRNA-128 plays a critical role in human non-small cell lung cancer tumourigenesis, angiogenesis and lymphangiogenesis by directly targeting vascular endothelial growth factor-C.
    Hu J; Cheng Y; Li Y; Jin Z; Pan Y; Liu G; Fu S; Zhang Y; Feng K; Feng Y
    Eur J Cancer; 2014 Sep; 50(13):2336-50. PubMed ID: 25001183
    [TBL] [Abstract][Full Text] [Related]  

  • 32. miR-6742-5p regulates the invasion and migration of lung adenocarcinoma cells via mediating FGF8/ERK12/MMP9/MMP2 signaling pathway.
    Song M; Xing X
    Aging (Albany NY); 2023 Jan; 15(1):53-69. PubMed ID: 36629518
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MiR-485-5p Suppress the Malignant Characteristics of the Lung Adenocarcinoma via Targeting NADPH Quinone Oxidoreductase-1 to Inhibit the PI3K/Akt.
    Chen Y; Wu L; Bao M
    Mol Biotechnol; 2023 May; 65(5):794-806. PubMed ID: 36219369
    [TBL] [Abstract][Full Text] [Related]  

  • 34. LINC00173.v1 promotes angiogenesis and progression of lung squamous cell carcinoma by sponging miR-511-5p to regulate VEGFA expression.
    Chen J; Liu A; Wang Z; Wang B; Chai X; Lu W; Cao T; Li R; Wu M; Lu Z; Pang W; Xiao L; Chen X; Zheng Y; Chen Q; Zeng J; Li J; Zhang X; Ren D; Huang Y
    Mol Cancer; 2020 May; 19(1):98. PubMed ID: 32473645
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MiR-182-5p inhibits colon cancer tumorigenesis, angiogenesis, and lymphangiogenesis by directly downregulating VEGF-C.
    Yan S; Wang H; Chen X; Liang C; Shang W; Wang L; Li J; Xu D
    Cancer Lett; 2020 Sep; 488():18-26. PubMed ID: 32473243
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Circular RNA circ_0067741 regulates the Hippo/YAP pathway to suppress lung adenocarcinoma progression by targeting microRNA-183-5p.
    Mo J; Nie H; Zeng C; Han H; Xu P; Shi X
    Bioengineered; 2022 Apr; 13(4):10165-10176. PubMed ID: 35435136
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Actin-like protein 8 promotes cell proliferation, colony-formation, proangiogenesis, migration and invasion in lung adenocarcinoma cells.
    Ma S; Wang X; Zhang Z; Liu D
    Thorac Cancer; 2020 Mar; 11(3):526-536. PubMed ID: 31962007
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Qingjie Fuzheng Granule suppresses lymphangiogenesis in colorectal cancer via the VEGF-C/VEGFR-3 dependent PI3K/AKT pathway.
    Huang B; Lu Y; Gui M; Guan J; Lin M; Zhao J; Mao Q; Lin J
    Biomed Pharmacother; 2021 May; 137():111331. PubMed ID: 33578235
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sinensetin inhibits the movement ability and tumor immune microenvironment of non-small cell lung cancer through the inactivation of AKT/β-catenin axis.
    Shi Z; Shen Y; Liu X; Zhang S
    J Biochem Mol Toxicol; 2024 Nov; 38(11):e70024. PubMed ID: 39434434
    [TBL] [Abstract][Full Text] [Related]  

  • 40. miR-31-5p modulates cell progression in lung adenocarcinoma through TNS1/p53 axis.
    Zhu C; Wang S; Zheng M; Chen Z; Wang G; Ma J; Zhang B; Huang W; Sun X; Wang C
    Strahlenther Onkol; 2022 Mar; 198(3):304-314. PubMed ID: 35037949
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.